MedPath
NMPA Approval

Amoxicillin Sodium and Clavulanate Potassium for Injection

国药准字HJ20120196

July 22, 2021

H20120196

Drug Information

注射用阿莫西林钠克拉维酸钾

莱得怡

注射剂

1.2g(C16H19N3O5S 1.0g与C8H9NO5 0.2g)

化学药品

July 22, 2021

July 21, 2026

Company Information

Applicant Company

Verovškova ulica 57, 1526 Ljubljana, Slovenia

Manufacturing Company

sandoz gmbh-betriebsstätte / manufacturing site anti infectives & chemical operations fdf kundl (aico fdf kundl)

Biochemiestraβe 10 6250 Kundl, Austria.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用阿莫西林钠克拉维酸钾 - NMPA 批准文号 | MedPath